RFG
GILD icon

REAP Financial Group’s Gilead Sciences GILD Stock Holding History

REAP Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
1,239
+11
+0.9% +$1.45K 0.03% 161
2026
Q1 		$171K Buy
1,228
+119
+11% +$16.7K 0.03% 147
2025
Q4 		$136K Buy
1,109
+437
+65% +$53.1K 0.03% 163
2025
Q3 		$74.6K Buy
672
+78
+13% +$8.87K 0.02% 225
2025
Q2 		$65.8K Buy
594
+288
+94% +$30.6K 0.02% 231
2025
Q1 		$34.3K Buy
306
+156
+104% +$16.1K 0.01% 248
2024
Q4 		$13.9K Buy
150
+55
+58% +$4.95K ﹤0.01% 328
2024
Q3 		$7.95K Sell
95
-14
-13% -$1.07K ﹤0.01% 398
2024
Q2 		$7.5K Buy
109
+4
+4% +$267 ﹤0.01% 377
2024
Q1 		$7.66K Sell
105
-1,322
-93% -$102K ﹤0.01% 404
2023
Q4 		$116K Buy
+1,427
New +$111K 0.03% 183

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

REAP Financial Group's GILD Position: Q2 2026 in Review

REAP Financial Group increased its Gilead Sciences (GILD) stake by 0.9% in Q2 2026, buying an estimated $1.45K and bringing the position to 1,239 shares worth $157K. The position accounts for 0.03% of the portfolio, ranked #161.

REAP Financial Group first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $171K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • REAP Financial Group held 1,239 shares of Gilead Sciences worth $157K as of Q2 2026.
  • REAP Financial Group bought 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
  • Gilead Sciences made up 0.03% of REAP Financial Group's portfolio in Q2 2026, its #161 holding.
  • REAP Financial Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • REAP Financial Group's Gilead Sciences position peaked at $171K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.